Artivion (AORT) Non-Current Deffered Revenue (2012 - 2026)
Artivion's (AORT) quarterly Non-Current Deffered Revenue came in at $9.7 million in Q1 2026, up 20.67% YoY from $8.1 million in Q1 2025, and up 2.9% on a QoQ basis from $9.5 million in Q4 2025.
Artivion (AORT) Non-Current Deffered Revenue (2012 - 2026) Analysis & Trends
Artivion (AORT) has 15 years of Non-Current Deffered Revenue data on file, last reported at $9.7 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 20.67% year-over-year to $9.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (up 20.67% YoY) and the FY2025 annual result came in at $9.5 million, up 18.3% from the prior year.
- Non-Current Deffered Revenue climbed to $9.7 million in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $9.7 million in Q1 2026 to a low of $5.1 million in Q3 2022.
- A 5-year average of $7.3 million and a median of $7.4 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue dropped 8.78% — and 2023, when it increased 27.12%.
- Tracing AORT's Non-Current Deffered Revenue over 5 years: stood at $5.5 million in 2022, then gained by 24.36% to $6.8 million in 2023, then increased by 17.65% to $8.0 million in 2024, then grew by 18.3% to $9.5 million in 2025, then grew by 2.9% to $9.7 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $9.7 million (Q1 2026), $9.5 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Artivion | 1.38 Bn | 1.30 Bn | 80.52 Mn | 10.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.74 Mn |
| Mar 31, 2026 | 9.74 Mn |
| Dec 31, 2025 | 9.46 Mn |
| Sep 30, 2025 | 9.19 Mn |
| Jun 30, 2025 | 8.73 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 7.93 Mn |
| Jun 30, 2024 | 7.46 Mn |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 6.80 Mn |
| Sep 30, 2023 | 6.46 Mn |
| Jun 30, 2023 | 6.54 Mn |
| Mar 31, 2023 | 6.13 Mn |
| Dec 31, 2022 | 5.47 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 5.15 Mn |
| Mar 31, 2022 | 5.77 Mn |
| Dec 31, 2021 | 5.95 Mn |
| Sep 30, 2021 | 5.57 Mn |